Clinical Trials In The News

These Clinical Trials have been featured in recent newspaper or magazine articles, or on the radio or TV:

• Gammaglobulin Liquid for Alzheimer’s Disease (GLAD) – The Alzheimer's Disease Cooperative Study will soon begin recruiting participants for a passive immunization trial of intravenous immunoglobulin (IGIv) for reducing brain amyloid. IGIv is a well-known treatment with an established safety record, approved for use for other indications for more than 25 years. Thirty-six to 40 sites are expected to participate through a partnership with Baxter Pharmaceuticals, recruiting 360 individuals between the ages of 55 to 90 with probable AD. Most sites will use home-health nurses to administer the IGIv bi-weekly for 72 weeks. Sign up for the IGIV Email Alert to receive updates on this study and the addition of new sites.

• Home-Based Assessment for Alzheimer Disease Prevention (HBA) is now recruiting participants.

• Alzheimer's Disease Genetics Study seeks families with 2 or more siblings with AD.

AD Genetics Study Brochure (PDF, 196K)

*E-mail Alerts* Subscribe to our AD Clinical Trials e-mail alert service.

E-mail us your questions about the Clinical Trials Database.

Back to Search